Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUPRIYA LIFESCIENCE Gains 4%; BSE HEALTHCARE Index Down 1.0%
Tue, 29 Oct 12:42

SUPRIYA LIFESCIENCE  Gains 4%; BSE HEALTHCARE Index Down 1.0%Image source: Eoneren/www.istockphoto.com

SUPRIYA LIFESCIENCE share price has zoomed 4% and is presently trading at Rs 579.3.

Meanwhile, the BSE HEALTHCARE index is at 42,998.1 (down 1.0%).

Among the top gainers in the BSE HEALTHCARE index today are CAPLIN POINT (up 3.1%) and MAX HEALTHCARE INSTITUTE (up 2.1%).

Glenmark Pharma (down 3.5%) and Dr. Reddys (down 3.2%) are among the top losers today.

Over the last one year, SUPRIYA LIFESCIENCE has moved up from Rs 242.6 to Rs 579.3, registering a gain of Rs 336.7 (up 138.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,318.2 to 42,998.1, registering a gain of 57.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 225.9%), Glenmark Pharma (up 120.2%) and SUVEN PHARMACEUTICALS (up 118.7%).

Don't Miss: Key Information for Long-term Investors

What About the Benchmark Indices?

The BSE Sensex is at 79,893.7 (down 0.1%).

The top losers among the BSE Sensex today are Tata Motors (down 3.7%) and Maruti Suzuki (down 1.9%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.

In the meantime, NSE Nifty is at 24,285.9 (down 0.2%). Tata Motors and IOC are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,049.1 to 79,893.7, registering a gain of 15,844.7 points (up 24.7%).

SUPRIYA LIFESCIENCE Financial Update...

SUPRIYA LIFESCIENCE net profit grew 93.2% YoY to Rs 461 million for the quarter ended September 2024, compared to a profit of Rs 239 million a year ago. Net sales rose 18.6% to Rs 1,661 million during the period as against Rs 1,401 million in July-September 2023.

For the year ended March 2024, SUPRIYA LIFESCIENCE reported 32.6% increase in net profit to Rs 1,191 million compared to net profit of Rs 899 million during FY23. Revenue of the company grew 21.8% to Rs 4,938 million during FY24.

The current Price to earnings ratio of SUPRIYA LIFESCIENCE , based on rolling 12 month earnings, stands at 29.6.


Equitymaster requests your view! Post a comment on "SUPRIYA LIFESCIENCE Gains 4%; BSE HEALTHCARE Index Down 1.0%". Click here!